Takeda Pharmaceutical
TAK
#370
Rank
C$95.16 B
Marketcap
C$29.79
Share price
0.33%
Change (1 day)
54.70%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2026 (TTM): C$0.77 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are C$29.55 Billion. In 2025 the company made an earning of C$4.69 Billion, an increase over its 2024 earnings that were of C$3.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.77 B-83.55%
2025 C$4.69 B49.03%
2024 C$3.15 B-2.41%
2023 C$3.22 B-28.14%
2022 C$4.49 B-40.9%
2021 C$7.60 B78.24%
2020 C$4.26 B246.1%
2019 C$1.23 B-48.79%
2018 C$2.40 B-23.64%
2017 C$3.15 B21.7%
2016 C$2.58 B-253.01%
2015 -C$1.7 Billion-159.65%
2014 C$2.83 B13%
2013 C$2.51 B2.46%
2012 C$2.45 B-57.05%
2011 C$5.70 B-10.49%
2010 C$6.37 B-3.99%
2009 C$6.63 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$26.43 B 3,523.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$17.85 B 2,347.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$9.75 B 1,236.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$14.52 B 1,891.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.11 B 1,285.97%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$10.86 B 1,388.50%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$10.10 B 1,284.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-C$1.12 Billion-253.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
C$0.60 B-17.25%๐Ÿ‡ฎ๐Ÿ‡ณ India